Clinical Trial Detail

NCT ID NCT01517802
Title A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

prostate cancer

breast cancer

Therapies

Abiraterone

Age Groups: adult child senior

No variant requirements are available.